Diagnostic nanoparticles could be used to monitor tumor recurrence after treatment or to perform routine cancer screenings.
A new study calculates the waste generated by N95 usage and suggests possible ways to reduce it.
Technique for editing bacterial genomes can record interactions between cells, may offer a way to edit genes in the human microbiome.
The tabletop diagnostic yields results in an hour and can be programmed to detect variants of the SARS-CoV-2 virus.
A new adhesive that mimics the sticky substance barnacles use to cling to rocks may offer a better way to treat traumatic injuries.
Blocking a key enzyme could kill parasites that have evolved resistance to existing drugs.
Studying these organoids could help researchers develop and test new treatments for pancreatic cancer, one of the deadliest types of cancer.
Using nanoparticles that store and gradually release light, engineers create light-emitting plants that can be charged repeatedly.
The new pill can inject large quantities of monoclonal antibodies and other drugs into the lining of the stomach after being swallowed.
A new finding from the Ragon Institute of MGH, MIT and Harvard may have implications for designing an effective AIDS vaccine.
MIT engineers devised a way to count elusive circulating tumor cells in mice, allowing them to study the dynamics of metastasis.
The technology could be developed as a rapid diagnostic for Covid-19 or other emerging pathogens.
A new RNA-based control switch could be used to trigger production of therapeutic proteins to treat cancer or other diseases.
The prevalence of auditory symptoms in Covid-19 patients is unknown, but infection of the inner ears may be responsible for hearing and balance problems.
Chemical engineers created a coating for microbes that could make it easier to deploy the organisms to treat gastrointestinal disease.
By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.
The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.
The device detects the same molecules that cell receptors do, and may enable routine early screening for cancers and other diseases.